Sweden
# |
Name |
Gross Profit Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
10,698.60%
|
Dec. 31, 2023 | USD 0.19 | -2.11% |
|
Sweden |
|
2 |
7,360.74%
|
Dec. 31, 2023 | USD 0.29 | 0.68% |
|
Sweden |
|
3 |
337.52%
|
Dec. 31, 2023 | USD 0.33 | 5.87% |
|
Sweden |
|
4 |
248.33%
|
Dec. 31, 2023 | USD 0.41 | 1.78% |
|
Sweden |
|
5 |
235.45%
|
Dec. 31, 2023 | USD 1.01 | -1.50% |
|
Sweden |
|
6 |
201.72%
|
Dec. 31, 2023 | USD 0.20 | 2.06% |
|
Sweden |
|
7 |
197.50%
|
Dec. 31, 2023 | USD 35.28 | 4.37% |
|
Sweden |
|
8 |
195.91%
|
Dec. 31, 2023 | USD 3.37 | 2.58% |
|
Sweden |
|
9 |
151.08%
|
Dec. 31, 2023 | USD 0.23 | -0.87% |
|
Sweden |
|
10 |
113.38%
|
Dec. 31, 2023 | USD 0.84 | -0.17% |
|
Sweden |
|
11 |
109.80%
|
Dec. 31, 2023 | USD 0.10 | 2.60% |
|
Sweden |
|
12 |
107.50%
|
Dec. 31, 2023 | USD 0.24 | -0.07% |
|
Sweden |
|
13 |
104.09%
|
Dec. 31, 2023 | USD 0.39 | -2.44% |
|
Sweden |
|
14 |
103.06%
|
Dec. 31, 2023 | USD 0.12 | -10.06% |
|
Sweden |
|
15 |
102.21%
|
Dec. 31, 2023 | USD 0.36 | -0.30% |
|
Sweden |
|
16 |
101.22%
|
Dec. 31, 2023 | USD 20.53 | 1.60% |
|
Sweden |
|
17 |
101.22%
|
Dec. 31, 2023 | USD 14.07 | 1.42% |
|
Sweden |
|
18 |
100.99%
|
Dec. 31, 2023 | USD 31.81 | -0.30% |
|
Sweden |
|
19 |
100.11%
|
Dec. 31, 2023 | USD 10.65 | 1.36% |
|
Sweden |
|
20 |
100.00%
|
Dec. 31, 2023 | USD 0.11 | 1.51% |
|
Sweden |
|
21 |
100.00%
|
Dec. 31, 2023 | USD 76.06 | 1.75% |
|
Sweden |
|
22 |
100.00%
|
Dec. 31, 2023 | USD 0.39 | 2.53% |
|
Sweden |
|
23 |
100.00%
|
Dec. 31, 2023 | USD 2.74 | 1.67% |
|
Sweden |
|
24 |
100.00%
|
Dec. 31, 2023 | USD 9.48 | 0.49% |
|
Sweden |
|
25 |
100.00%
|
Dec. 31, 2023 | USD 4.07 | -5.72% |
|
Sweden |
|
26 |
100.00%
|
Dec. 31, 2023 | USD 1.17 | -3.73% |
|
Sweden |
|
27 |
100.00%
|
Dec. 31, 2023 | USD 0.10 | 0.68% |
|
Sweden |
|
28 |
100.00%
|
Dec. 31, 2023 | USD 23.97 | -1.16% |
|
Sweden |
|
29 |
100.00%
|
Dec. 31, 2023 | USD 0.71 | -2.02% |
|
Sweden |
|
30 |
100.00%
|
Dec. 31, 2023 | USD 0.45 | 23.08% |
|
Sweden |
|
31 |
100.00%
|
Dec. 31, 2023 | USD 1.55 | 1.85% |
|
Sweden |
|
32 |
99.90%
|
Dec. 31, 2023 | USD 0.23 | 11.53% |
|
Sweden |
|
33 |
99.31%
|
Dec. 31, 2023 | USD 0.53 | -3.21% |
|
Sweden |
|
34 |
98.27%
|
Dec. 31, 2023 | USD 7.30 | 0.92% |
|
Sweden |
|
35 |
98.12%
|
Dec. 31, 2023 | USD 1.88 | 0.68% |
|
Sweden |
|
36 |
97.66%
|
Dec. 31, 2023 | USD 0.78 | 5.47% |
|
Sweden |
|
37 |
96.03%
|
Dec. 31, 2023 | USD 0.50 | 11.06% |
|
Sweden |
|
38 |
94.33%
|
April 30, 2024 | USD 0.16 | -0.98% |
|
Sweden |
|
39 |
92.87%
|
Dec. 31, 2023 | USD 51.72 | -0.10% |
|
Sweden |
|
40 |
92.86%
|
Dec. 31, 2023 | USD 22.31 | 2.31% |
|
Sweden |
|
41 |
92.69%
|
Aug. 31, 2024 | USD 0.96 | -2.04% |
|
Sweden |
|
42 |
92.61%
|
Dec. 31, 2023 | USD 0.36 | -8.08% |
|
Sweden |
|
43 |
91.51%
|
Dec. 31, 2023 | USD 32.97 | -0.61% |
|
Sweden |
|
44 |
91.50%
|
Dec. 31, 2023 | USD 8.39 | 3.65% |
|
Sweden |
|
45 |
90.42%
|
Dec. 31, 2023 | USD 2.09 | -2.04% |
|
Sweden |
|
46 |
90.40%
|
Dec. 31, 2023 | USD 5.06 | 2.85% |
|
Sweden |
|
47 |
89.69%
|
Dec. 31, 2023 | USD 3.31 | 2.33% |
|
Sweden |
|
48 |
89.57%
|
Dec. 31, 2023 | USD 20.58 | 0.68% |
|
Sweden |
|
49 |
89.35%
|
Dec. 31, 2023 | USD 5.20 | 1.37% |
|
Sweden |
|
50 |
89.26%
|
Dec. 31, 2023 | USD 25.00 | 2.25% |
|
Sweden |
The company in Sweden with the highest Gross Profit Margin is Minesto AB (publ) (Stockholm Stock Exchange: MINEST.ST) at 10,698.60%.
The company in Sweden with the lowest Gross Profit Margin is Isofol Medical AB (publ) (Stockholm Stock Exchange: ISOFOL.ST) at -4,773.23%.
The top 10 companies in Sweden by Gross Profit Margin are Minesto AB (publ), Alzinova AB (publ), SaltX Technology Holding AB (publ), Iconovo AB (publ), CARBIOTIX AB, Nanexa AB (publ), TF Bank AB (publ), Norion Bank AB, Kontigo Care AB (publ) and Corline Biomedical AB.
The bottom 10 companies in Sweden by Gross Profit Margin are Isofol Medical AB (publ), SpectraCure AB (publ), Diamyd Medical AB (publ), Qlife Holding AB (publ), IRLAB Therapeutics AB (publ), Prostatype Genomics AB (publ), Crunchfish AB (publ), NextCell Pharma AB, CombiGene AB (publ) and Enorama Pharma AB (publ).